Practice parameter for the diagnosis and management of primary immunodeficiency

Francisco A Bonilla; Zuhair K Ballas; David A Khan; Javier Chinen; Michael M Frank; Joyce T Hsu; Hirsh D Komarow; Bruce Mazer; Robert P Nelson Jr; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen; James W Verbsky; David I Bernstein; Joann Blessing-Moore; David Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace; Joint Task Force on Practice Parameters for Allergy, Asthma & Immunology

doi:10.1016/j.jaci.2015.04.049

Back

Practice parameter for the diagnosis and management of primary immunodeficiency

Journal article

Open access

Peer reviewed

Practice parameter for the diagnosis and management of primary immunodeficiency

Francisco A Bonilla, Zuhair K Ballas, David A Khan, Javier Chinen, Michael M Frank, Joyce T Hsu, Hirsh D Komarow, Bruce Mazer, Robert P Nelson Jr, Jordan S Orange, …

Journal of allergy and clinical immunology, Vol.136(5), pp.1186-1205.e78

11/2015

DOI: 10.1016/j.jaci.2015.04.049

PMID: 26371839

Files and links (1)

url

https://doi.org/10.1016/j.jaci.2015.04.049View

Published (Version of record) Open Access

Abstract

The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

Immunologic Deficiency Syndromes - therapy

Animals

Humans

Clinical Trials as Topic

Disease Management

Evidence-Based Medicine

Immunologic Deficiency Syndromes - diagnosis

Advisory Committees

Details

Title: Subtitle: Practice parameter for the diagnosis and management of primary immunodeficiency
Creators: Francisco A Bonilla
Zuhair K Ballas
David A Khan
Javier Chinen
Michael M Frank
Joyce T Hsu
Hirsh D Komarow
Bruce Mazer
Robert P Nelson Jr
Jordan S Orange
John M Routes
William T Shearer
Ricardo U Sorensen
James W Verbsky
David I Bernstein
Joann Blessing-Moore
David Lang
Richard A Nicklas
John Oppenheimer
Jay M Portnoy
Christopher R Randolph
Diane Schuller
Sheldon L Spector
Stephen Tilles
Dana Wallace
Joint Task Force on Practice Parameters for Allergy, Asthma & Immunology
Resource Type: Journal article
Publication Details: Journal of allergy and clinical immunology, Vol.136(5), pp.1186-1205.e78
DOI: 10.1016/j.jaci.2015.04.049
PMID: 26371839
ISSN: 0091-6749
eISSN: 1097-6825
Grant note: Intramural NIH HHS
Language: English
Date published: 11/2015
Academic Unit: Immunology; Internal Medicine
Record Identifier: 9984094563802771

Metrics

27 Record Views

477 Times Cited - Web of Science

See more details